Jiuzhitang Co., Ltd. (SHE:000989)

China flag China · Delayed Price · Currency is CNY
9.74
-0.08 (-0.81%)
Apr 29, 2026, 3:04 PM CST
9.44%
Market Cap 8.24B
Revenue (ttm) 2.23B
Net Income (ttm) 222.60M
Shares Out 846.28M
EPS (ttm) 0.26
PE Ratio 37.03
Forward PE n/a
Dividend 0.30 (3.05%)
Ex-Dividend Date May 8, 2025
Volume 19,573,311
Average Volume 23,489,765
Open 9.87
Previous Close 9.82
Day's Range 9.60 - 9.87
52-Week Range 7.98 - 13.30
Beta 0.34
RSI 55.89
Earnings Date Aug 24, 2026

About Jiuzhitang

Jiuzhitang Co., Ltd. provides traditional Chinese, chemical, biological, and health medicine products in China. It offers Shuxuetong injections, Angong Niuhuang pills, Tianma Gouteng granules, Danxi granules, and Compound Lipid-Reducing tablets for cardiovascular and neurological treatment; Nude Flower Zizhu tablets, Xiaojin pills, Guizhi Fuling pills, Buxue Shengru granules, and Zhixue Zhentong capsules for gynecological treatment; Houyan pills for ear, nose, and throat (ENT) diseases; Jianwei Yuyang tablets for digestion; and prescription dru... [Read more]

Sector Healthcare
Founded 1999
Employees 3,674
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000989
Full Company Profile

Financial Performance

In 2025, Jiuzhitang's revenue was 2.23 billion, a decrease of -5.99% compared to the previous year's 2.37 billion. Earnings were 222.60 million, an increase of 2.96%.

Financial Statements

News

There is no news available yet.